AIM IMMUNOTECH INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
AIM IMMUNOTECH INC. (AIM) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$2.93 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-27
- AIM IMMUNOTECH INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$2.93M.
- AIM IMMUNOTECH INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$3.64M.
- AIM IMMUNOTECH INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$6.08M.
- AIM IMMUNOTECH INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$4.09M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$2.93M 10-K · filed 2026-03-27 |
| 2024-12-31 | -$3.64M 10-K · filed 2025-03-27 |
| 2023-12-31 | -$6.08M 10-K · filed 2024-04-01 |
| 2022-12-31 | -$4.09M 10-K · filed 2023-03-31 |
| 2021-12-31 | -$4.02M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |